secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2025-07-16T23:59:59+00:00
Accession:  0001193125-25-159793
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics raises $3.0M via stock and warrant offering; suspends ATM facility
--------------------------------------------------------------------------------

- Entered securities purchase agreement to issue 4.354M shares and 3.146M pre-funded warrants at $0.40/share.
- Gross proceeds expected to be ~$3.0M; closing expected on July 16, 2025.
- Suspended its Controlled Equity Offering ATM program with H.C. Wainwright.
- Directors and officers entered into 45-day lock-up agreements.
- Placement agent Maxim Group LLC receives 5.25% cash fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312525159793/0001193125-25-159793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312525159793/d917538d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-159793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer